Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Development Of Precision Medicine
3.2. Key Drivers
3.2.1. Usage Of Digital Collaboration In Exchanging Useful Information For Developing Precision Medicine
3.2.2. Identification And Characterization Of Essential Genes In The Human Genome
3.2.3. Investments By Government And Private Players To Find Effective Treatments For Different Types Of Cancers
3.2.4. Prevalence Of Precision Medicine To Tackle Chronic Conditions
3.2.5. Demand For Preventive Care
3.3. Key Restraints
3.3.1. Security Risks Associated With Data Sharing
3.3.2. Difficulty In Acquiring Pharmacotherapy Approval For A New Drug
3.3.3. Uncertainty Associated With Reimbursement And Regulatory Policies

4. Key Analytics
4.1. Impact Of Covid-19 On Precision Medicine Market
4.2. Key Investment Insights
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entries
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Technologies Related To Precision Medicine
4.7. Supply Chain Analysis

5. Market By Application
5.1. Oncology
5.2. Infectious Diseases
5.3. Neurology/Physiatry
5.4. Cardiovascular
5.5. Lifestyle And Endocrinology
5.6. Gastroenterology
5.7. Other Applications

6. Market By Component
6.1. Applied Science
6.1.1. Genomics
6.1.1.1. Pcr
6.1.1.2. Pm Ngs
6.1.1.3. Genome Editing
6.1.1.4. Other Genomics Technologies
6.1.2. Pharmacogenomics
6.1.3. Other Applied Sciences
6.2. Precision Therapeutics
6.2.1. Clinical Trials
6.2.2. Cell Therapy
6.2.3. Drug Discovery And Research
6.2.4. Gene Therapy
6.3. Precision Diagnostics
6.3.1. Molecular Diagnostics
6.3.1.1. Non-Invasive Prenatal Testing (Nipt)
6.3.1.2. Companion Diagnostics
6.3.1.3. Liquid Biopsy
6.3.1.4. Other Molecular Diagnostics
6.3.2. Medical Imaging
6.3.2.1. Imaging Analytics
6.3.2.2. Imaging Computer-Aided Detection (Cadx)
6.4. Digital Health And Information Technology
6.4.1. Clinical Decision Support Systems (Cdss)
6.4.2. Big Data Analytics
6.4.3. It Infrastructure
6.4.4. Genomics Informatics
6.4.5. In-Silico Informatics
6.4.6. Mobile Health

7. Geographical Analysis
7.1. Europe
7.1.1. Market Size & Estimates
7.1.2. Key Growth Enablers
7.1.3. Key Challenges
7.1.4. Key Players
7.1.5. Country Analysis
7.1.5.1. Germany
7.1.5.2. France
7.1.5.3. United Kingdom
7.1.5.4. Italy
7.1.5.5. Russia
7.1.5.6. Belgium
7.1.5.7. Poland
7.1.5.8. Rest Of Europe

8. Competitive Landscape
8.1. Key Strategic Developments
8.1.1. Mergers & Acquisitions
8.1.2. Product Launches & Developments
8.1.3. Partnerships, Contracts/Agreements & Collaborations
8.1.4. Business Expansions/ Approvals/ Announcements
8.2. Company Profiles
8.2.1. Abbott Laboratories
8.2.2. Astra Zeneca Plc
8.2.3. Biocrates Life Sciences Ag
8.2.4. Bio-Rad Laboratories Inc
8.2.5. Danaher Corporation
8.2.6. Eagle Genomics Ltd
8.2.7. Eli Lilly & Company
8.2.8. F. Hoffmann-La Roche
8.2.9. Intomics
8.2.10. Laboratory Corporation Of America Holdings
8.2.11. Nanostring Technologies
8.2.12. Novartis Ag
8.2.13. Pfizer Inc
8.2.14. Qiagen Nv
8.2.15. Quest Diagnostics Incorporated



List of Figures


Figure 1: Key Investment Insights
Figure 2: Porter’S Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Europe Precision Medicine Market, By Application, In 2020
Figure 6: Europe Precision Medicine Market, By Oncology, 2021-2028 (In $ Million)
Figure 7: Europe Precision Medicine Market, By Infectious Diseases, 2021-2028 (In $ Million)
Figure 8: Europe Precision Medicine Market, By Neurology/Physiatry, 2021-2028 (In $ Million)
Figure 9: Europe Precision Medicine Market, By Cardiovascular, 2021-2028 (In $ Million)
Figure 10: Europe Precision Medicine Market, By Lifestyle And Endocrinology, 2021-2028 (In $ Million)
Figure 11: Europe Precision Medicine Market, By Gastroenterology, 2021-2028 (In $ Million)
Figure 12: Europe Precision Medicine Market, By Other Applications,2021-2028 (In $ Million)
Figure 13: Europe Precision Medicine Market, By Component, In 2020
Figure 14: Europe Precision Medicine Market, By Applied Science, 2021-2028 (In $ Million)
Figure 15: Europe Applied Science Market, By Genomics, 2021-2028 (In $ Million)
Figure 16: Europe Genomics Market, By Pcr, 2021-2028 (In $ Million)
Figure 17: Europe Genomics Market, By Pm Ngs, 2021-2028 (In $ Million)
Figure 18: Europe Genomics Market, By Genome Editing, 2021-2028 (In $ Million)
Figure 19: Europe Genomics Market, By Other Genomics Technologies, 2021-2028 (In $ Million)
Figure 20: Europe Applied Science Market, By Pharmacogenomics, 2021-2028 (In $ Million)
Figure 21: Biomarker’S Role In Pharmacogenomics
Figure 22: Europe Applied Sciences Market, By Other Applied Sciences, 2021-2028 (In $ Million)
Figure 23: Europe Precision Medicine Market, By Precision Therapeutics, 2021-2028 (In $ Million)
Figure 24: Europe Precision Therapeutics Market, By Clinical Trials, 2021-2028 (In $ Million)
Figure 25: Europe Precision Therapeutics Market, By Cell Therapy, 2021-2028 (In $ Million)
Figure 26: Europe Precision Therapeutics Market, By Drug Discovery And Research, 2021-2028 (In $ Million)
Figure 27: Europe Precision Therapeutics Market, By Gene Therapy, 2021-2028 (In $ Million)
Figure 28: Europe Precision Medicine Market, By Precision Diagnostics, 2021-2028 (In $ Million)
Figure 29: Europe Precision Diagnostics Market, By Molecular Diagnostics, 2021-2028 (In $ Million)
Figure 30: Europe Molecular Diagnostics Market, By Non-Invasive Prenatal Testing (Nipt), 2021-2028 (In $ Million)
Figure 31: Europe Molecular Diagnostics Market, By Companion Diagnostics, 2021-2028 (In $ Million)
Figure 32: Europe Molecular Diagnostics Market, By Liquid Biopsy, 2021-2028 (In $ Million)
Figure 33: Europe Molecular Diagnostics Market, By Other Molecular Diagnostics, 2021-2028 (In $ Million)
Figure 34: Europe Precision Diagnostics Market, By Medical Imaging, 2021-2028 (In $ Million)
Figure 35: Europe Medical Imaging Market, By Imaging Analytics, 2021-2028 (In $ Million)
Figure 36: Europe Medical Imaging Market, By Imaging Computer-Aided Detection (Cadx), 2021-2028 (In $ Million)
Figure 37: Europe Precision Medicine Market, By Digital Health And Information Technology, 2021-2028 (In $ Million)
Figure 38: Europe Digital Health And Information Technology Market, By Clinical Decision Support Systems (Cdss), 2021-2028 (In $ Million)
Figure 39: Europe Digital Health And Information Technology Market, By Big Data Analytics, 2021-2028 (In $ Million)
Figure 40: Europe Digital Health And Information Technology Market, By It Infrastructure, 2021-2028 (In $ Million)
Figure 41: Europe Digital Health And Information Technology Market, By Genomics Informatics, 2021-2028 (In $ Million)
Figure 42: Europe Digital Health And Information Technology Market, By In-Silico Informatics, 2021-2028 (In $ Million)
Figure 43: Europe Digital Health And Information Technology Market, By Mobile Health, 2021-2028 (In $ Million)
Figure 44: Europe Precision Medicine Market, Country Outlook, 2020 & 2028 (In %)
Figure 45: Germany Precision Medicine Market, 2021-2028 (In $ Million)
Figure 46: France Precision Medicine Market, 2021-2028 (In $ Million)
Figure 47: United Kingdom Precision Medicine Market, 2021-2028 (In $ Million)
Figure 48: Italy Precision Medicine Market, 2021-2028 (In $ Million)
Figure 49: Russia Precision Medicine Market, 2021-2028 (In $ Million)
Figure 50: Belgium Precision Medicine Market, 2021-2028 (In $ Million)
Figure 51: Poland Precision Medicine Market, 2021-2028 (In $ Million)
Figure 52: Rest Of Europe Precision Medicine Market, 2021-2028 (In $ Million)


List of Tables


TABLE 1: MARKET SNAPSHOT - PRECISION MEDICINE
TABLE 2: EUROPE PRECISION MEDICINE MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: EUROPE PRECISION MEDICINE MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: EUROPE PRECISION MEDICINE MARKET, BY COMPONENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: EUROPE PRECISION MEDICINE MARKET, BY COMPONENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: EUROPE APPLIED SCIENCE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: EUROPE APPLIED SCIENCE MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: EUROPE GENOMICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: EUROPE GENOMICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: EUROPE PRECISION THERAPEUTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: EUROPE PRECISION THERAPEUTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: EUROPE PRECISION DIAGNOSTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: EUROPE PRECISION DIAGNOSTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: EUROPE MOLECULAR DIAGNOSTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 15: EUROPE MOLECULAR DIAGNOSTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 16: EUROPE MEDICAL IMAGING MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 17: EUROPE MEDICAL IMAGING MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 18: EUROPE DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 19: EUROPE DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION
TABLE 20: EUROPE PRECISION MEDICINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 21: EUROPE PRECISION MEDICINE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 22: LEADING PLAYERS OPERATING IN EUROPE PRECISION MEDICINE MARKET
TABLE 23: LIST OF MERGERS & ACQUISITIONS
TABLE 24: LIST OF PRODUCTS LAUNCHES & DEVELOPMENTS
TABLE 25: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 26: LIST OF BUSINESS EXPANSIONS & DIVESTITURES